Status:
RECRUITING
Biologics and Clinical Immunology Cohort At Sinai
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Immunological Disease
Autoimmune Diseases
Eligibility:
All Genders
12+ years
Brief Summary
The study team plans to establish a bioregistry of patients receiving biologic therapy as part of their standard treatment at the Mount Sinai Therapeutic Infusion Center and affiliated practices. The ...
Detailed Description
The study team proposes a twofold approach to determine how immunophenotype may affect the course of clinical immunological disease for patients receiving biologic therapy. First, the team intends to ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 12 years and up.
- Able to provide informed consent.
- Medical care at Mount Sinai.
- Receiving a biologic medication or immune modulator at Mount Sinai, or considered an appropriate negative control or comparison participant by the study team.
Exclusion
Key Trial Info
Start Date :
March 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04784364
Start Date
March 3 2021
End Date
November 1 2028
Last Update
November 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai
New York, New York, United States, 10029